Global Metastatic Cancer Treatment Market 2018 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.
    In 2017, the global Metastatic Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
    
    This report focuses on the global Metastatic Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Cancer Treatment development in United States, Europe and China.
    
    The key players covered in this study
        Roche
        Novartis
        Merck
        Eli Lilly
        Johnson & Johnson
        Pfizer
        AstraZeneca
        GlaxoSmithKline
        Sun Pharmaceutical
        Bayer
        Gilead Sciences
    
    Market segment by Type, the product can be split into
        Chemotherapy
        Radiation Therapy
        Biologic Targeted Therapy
        Breast Surgery
        Hormone Therapy
    
    Market segment by Application, split into
        Hospitals
        Clinics
        Other
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Metastatic Cancer Treatment status, future forecast, growth opportunity, key market and key players.
        To present the Metastatic Cancer Treatment development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Metastatic Cancer Treatment are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Metastatic Cancer Treatment Market Size Growth Rate by Type (2013-2025)
            1.4.2 Chemotherapy
            1.4.3 Radiation Therapy
            1.4.4 Biologic Targeted Therapy
            1.4.5 Breast Surgery
            1.4.6 Hormone Therapy
        1.5 Market by Application
            1.5.1 Global Metastatic Cancer Treatment Market Share by Application (2013-2025)
            1.5.2 Hospitals
            1.5.3 Clinics
            1.5.4 Other
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Metastatic Cancer Treatment Market Size
        2.2 Metastatic Cancer Treatment Growth Trends by Regions
            2.2.1 Metastatic Cancer Treatment Market Size by Regions (2013-2025)
            2.2.2 Metastatic Cancer Treatment Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Metastatic Cancer Treatment Market Size by Manufacturers
            3.1.1 Global Metastatic Cancer Treatment Revenue by Manufacturers (2013-2018)
            3.1.2 Global Metastatic Cancer Treatment Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Metastatic Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.2 Metastatic Cancer Treatment Key Players Head office and Area Served
        3.3 Key Players Metastatic Cancer Treatment Product/Solution/Service
        3.4 Date of Enter into Metastatic Cancer Treatment Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Metastatic Cancer Treatment Market Size by Type (2013-2018)
        4.2 Global Metastatic Cancer Treatment Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Metastatic Cancer Treatment Market Size (2013-2018)
        5.2 Metastatic Cancer Treatment Key Players in United States
        5.3 United States Metastatic Cancer Treatment Market Size by Type
        5.4 United States Metastatic Cancer Treatment Market Size by Application
    
    6 Europe
        6.1 Europe Metastatic Cancer Treatment Market Size (2013-2018)
        6.2 Metastatic Cancer Treatment Key Players in Europe
        6.3 Europe Metastatic Cancer Treatment Market Size by Type
        6.4 Europe Metastatic Cancer Treatment Market Size by Application
    
    7 China
        7.1 China Metastatic Cancer Treatment Market Size (2013-2018)
        7.2 Metastatic Cancer Treatment Key Players in China
        7.3 China Metastatic Cancer Treatment Market Size by Type
        7.4 China Metastatic Cancer Treatment Market Size by Application
    
    8 Japan
        8.1 Japan Metastatic Cancer Treatment Market Size (2013-2018)
        8.2 Metastatic Cancer Treatment Key Players in Japan
        8.3 Japan Metastatic Cancer Treatment Market Size by Type
        8.4 Japan Metastatic Cancer Treatment Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Metastatic Cancer Treatment Market Size (2013-2018)
        9.2 Metastatic Cancer Treatment Key Players in Southeast Asia
        9.3 Southeast Asia Metastatic Cancer Treatment Market Size by Type
        9.4 Southeast Asia Metastatic Cancer Treatment Market Size by Application
    
    10 India
        10.1 India Metastatic Cancer Treatment Market Size (2013-2018)
        10.2 Metastatic Cancer Treatment Key Players in India
        10.3 India Metastatic Cancer Treatment Market Size by Type
        10.4 India Metastatic Cancer Treatment Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Metastatic Cancer Treatment Market Size (2013-2018)
        11.2 Metastatic Cancer Treatment Key Players in Central & South America
        11.3 Central & South America Metastatic Cancer Treatment Market Size by Type
        11.4 Central & South America Metastatic Cancer Treatment Market Size by Application
    
    12 International Players Profiles
        12.1 Roche
            12.1.1 Roche Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Metastatic Cancer Treatment Introduction
            12.1.4 Roche Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.1.5 Roche Recent Development
        12.2 Novartis
            12.2.1 Novartis Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Metastatic Cancer Treatment Introduction
            12.2.4 Novartis Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.2.5 Novartis Recent Development
        12.3 Merck
            12.3.1 Merck Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Metastatic Cancer Treatment Introduction
            12.3.4 Merck Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.3.5 Merck Recent Development
        12.4 Eli Lilly
            12.4.1 Eli Lilly Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Metastatic Cancer Treatment Introduction
            12.4.4 Eli Lilly Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.4.5 Eli Lilly Recent Development
        12.5 Johnson & Johnson
            12.5.1 Johnson & Johnson Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Metastatic Cancer Treatment Introduction
            12.5.4 Johnson & Johnson Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.5.5 Johnson & Johnson Recent Development
        12.6 Pfizer
            12.6.1 Pfizer Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Metastatic Cancer Treatment Introduction
            12.6.4 Pfizer Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.6.5 Pfizer Recent Development
        12.7 AstraZeneca
            12.7.1 AstraZeneca Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Metastatic Cancer Treatment Introduction
            12.7.4 AstraZeneca Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.7.5 AstraZeneca Recent Development
        12.8 GlaxoSmithKline
            12.8.1 GlaxoSmithKline Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Metastatic Cancer Treatment Introduction
            12.8.4 GlaxoSmithKline Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.8.5 GlaxoSmithKline Recent Development
        12.9 Sun Pharmaceutical
            12.9.1 Sun Pharmaceutical Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Metastatic Cancer Treatment Introduction
            12.9.4 Sun Pharmaceutical Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.9.5 Sun Pharmaceutical Recent Development
        12.10 Bayer
            12.10.1 Bayer Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Metastatic Cancer Treatment Introduction
            12.10.4 Bayer Revenue in Metastatic Cancer Treatment Business (2013-2018)
            12.10.5 Bayer Recent Development
        12.11 Gilead Sciences
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Metastatic Cancer Treatment Key Market Segments
        Table Key Players Metastatic Cancer Treatment Covered
        Table Global Metastatic Cancer Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Metastatic Cancer Treatment Market Size Market Share by Type 2013-2025
        Figure Chemotherapy Figures
        Table Key Players of Chemotherapy
        Figure Radiation Therapy Figures
        Table Key Players of Radiation Therapy
        Figure Biologic Targeted Therapy Figures
        Table Key Players of Biologic Targeted Therapy
        Figure Breast Surgery Figures
        Table Key Players of Breast Surgery
        Figure Hormone Therapy Figures
        Table Key Players of Hormone Therapy
        Table Global Metastatic Cancer Treatment Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospitals Case Studies
        Figure Clinics Case Studies
        Figure Other Case Studies
        Figure Metastatic Cancer Treatment Report Years Considered
        Table Global Metastatic Cancer Treatment Market Size 2013-2025 (Million US$)
        Figure Global Metastatic Cancer Treatment Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Metastatic Cancer Treatment Market Size by Regions 2013-2025 (Million US$)
        Table Global Metastatic Cancer Treatment Market Size by Regions 2013-2018 (Million US$)
        Table Global Metastatic Cancer Treatment Market Share by Regions 2013-2018
        Figure Global Metastatic Cancer Treatment Market Share by Regions 2013-2018
        Figure Global Metastatic Cancer Treatment Market Share by Regions 2018
        Table Market Top Trends
        Table Global Metastatic Cancer Treatment Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Metastatic Cancer Treatment Market Share by Manufacturers (2013-2018)
        Figure Global Metastatic Cancer Treatment Market Share by Manufacturers in 2018
        Table Global Metastatic Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Metastatic Cancer Treatment Product/Solution/Service
        Table Date of Enter into Metastatic Cancer Treatment Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table Global Metastatic Cancer Treatment Market Size Share by Type (2013-2018)
        Figure Global Metastatic Cancer Treatment Market Size Market Share by Type (2013-2018)
        Table Global Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table Global Metastatic Cancer Treatment Market Size Share by Application (2013-2018)
        Figure Global Metastatic Cancer Treatment Market Size Market Share by Application (2013-2018)
        Figure Global Metastatic Cancer Treatment Revenue Market Share by Application in 2017
        Figure United States Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table United States Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table United States Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table United States Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table United States Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table United States Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table United States Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Figure Europe Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table Europe Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table Europe Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table Europe Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table Europe Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table Europe Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table Europe Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Figure China Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table China Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table China Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table China Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table China Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table China Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table China Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Figure Japan Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table Japan Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table Japan Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table Japan Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table Japan Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table Japan Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table Japan Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Figure Southeast Asia Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table Southeast Asia Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table Southeast Asia Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Figure India Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table India Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table India Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table India Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table India Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table India Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table India Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Figure Central & South America Metastatic Cancer Treatment Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Metastatic Cancer Treatment Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Metastatic Cancer Treatment Market Share (2017-2018)
        Table Central & South America Metastatic Cancer Treatment Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Metastatic Cancer Treatment Market Share by Type (2013-2018)
        Table Central & South America Metastatic Cancer Treatment Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Metastatic Cancer Treatment Market Share by Application (2013-2018)
        Table Roche Company Details
        Table Roche Revenue in Metastatic Cancer Treatment Business (2013-2018) (Million US$)
        Figure Roche Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Roche Recent Development
        Table Novartis Company Details
        Table Novartis Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Novartis Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Novartis Recent Development
        Table Merck Company Details
        Table Merck Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Merck Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Merck Recent Development
        Table Eli Lilly Company Details
        Table Eli Lilly Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Eli Lilly Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Eli Lilly Recent Development
        Table Johnson & Johnson Company Details
        Table Johnson & Johnson Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Johnson & Johnson Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Johnson & Johnson Recent Development
        Table Pfizer Company Details
        Table Pfizer Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Pfizer Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Pfizer Recent Development
        Table AstraZeneca Company Details
        Table AstraZeneca Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure AstraZeneca Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table AstraZeneca Recent Development
        Table GlaxoSmithKline Company Details
        Table GlaxoSmithKline Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure GlaxoSmithKline Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table GlaxoSmithKline Recent Development
        Table Sun Pharmaceutical Company Details
        Table Sun Pharmaceutical Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Sun Pharmaceutical Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Sun Pharmaceutical Recent Development
        Table Bayer Company Details
        Table Bayer Revenue in Metastatic Cancer Treatment Business (2013-2018)(Million US$)
        Figure Bayer Revenue Growth Rate in Metastatic Cancer Treatment Business (2013-2018)
        Table Bayer Recent Development
        Table Gilead Sciences Company Details
        Table Global Metastatic Cancer Treatment Market Size by Regions (Million US$) 2018-2025
        Figure Global Metastatic Cancer Treatment Market Size Share by Regions (2018-2025)
        Figure Global Metastatic Cancer Treatment Market Size Share by Regions in 2025
        Figure United States Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure China Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure India Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Metastatic Cancer Treatment Market Size Forecast (2018-2025)(Million USD)
        Table Global Metastatic Cancer Treatment Market Size by Product (2018-2025) (Million US$)
        Figure Global Metastatic Cancer Treatment Market Size by Product (2018-2025)
        Figure Global Metastatic Cancer Treatment Market Size by Product in 2025
        Table Global Metastatic Cancer Treatment Market Size by Application (2018-2025) (Million US$)
        Figure Global Metastatic Cancer Treatment Market Size by Application (2018-2025)
        Figure Global Metastatic Cancer Treatment Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources